Fibrocell Science, Inc. (FCSC) Analysts See $-0.23 EPS; Last Week Credit Suisse Group AG (CS) Analysts

February 23, 2018 - By Linda Rogers

Analysts expect Fibrocell Science, Inc. (NASDAQ:FCSC) to report $-0.23 EPS on March, 8.They anticipate $0.12 EPS change or 109.09% from last quarter’s $-0.11 EPS. After having $-0.34 EPS previously, Fibrocell Science, Inc.’s analysts see -32.35% EPS growth. The stock decreased 8.00% or $0.053 during the last trading session, reaching $0.605. About 1.48 million shares traded or 105.35% up from the average. Fibrocell Science, Inc. (NASDAQ:FCSC) has declined 57.80% since February 23, 2017 and is downtrending. It has underperformed by 74.50% the S&P500.

Among 12 analysts covering Credit Suisse Group Ag (NYSE:CS), 9 have Buy rating, 1 Sell and 2 Hold. Therefore 75% are positive. Credit Suisse Group Ag had 24 analyst reports since July 28, 2015 according to SRatingsIntel. On Friday, November 4 the stock rating was downgraded by Macquarie Research to “Neutral”. The firm has “Neutral” rating given on Wednesday, November 15 by Macquarie Research. The stock of Credit Suisse Group AG (NYSE:CS) earned “Buy” rating by Deutsche Bank on Monday, June 19. The stock of Credit Suisse Group AG (NYSE:CS) has “Overweight” rating given on Thursday, December 8 by JP Morgan. Bank of America upgraded the shares of CS in report on Friday, May 20 to “Neutral” rating. The firm earned “Sector Perform” rating on Tuesday, June 28 by RBC Capital Markets. The firm earned “Underperform” rating on Friday, January 13 by Macquarie Research. On Friday, February 5 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. The stock has “Buy” rating by Morgan Stanley on Tuesday, June 20. On Wednesday, August 26 the stock rating was upgraded by Vetr to “Hold”. See Credit Suisse Group AG (NYSE:CS) latest ratings:

15/02/2018 Broker: Societe Generale Rating: Buy Upgrade
16/01/2018 Broker: Barclays Capital Rating: Sell Initiate
09/01/2018 Broker: Societe Generale Rating: Hold New Target: $18.5 Downgrade
15/11/2017 Broker: Macquarie Research Old Rating: Underperform New Rating: Neutral Upgrade
06/10/2017 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Outperform Upgrade
12/09/2017 Broker: Societe Generale Old Rating: Hold New Rating: Buy Upgrade

The stock decreased 0.16% or $0.03 during the last trading session, reaching $18.56. About 2.51 million shares traded. Credit Suisse Group AG (NYSE:CS) has risen 6.69% since February 23, 2017 and is uptrending. It has underperformed by 10.01% the S&P500.

Credit Suisse Group AG, together with its subsidiaries, provides various financial services worldwide. The company has market cap of $47.76 billion. It operates through Swiss Universal Bank, International Wealth Management, Asia Pacific, Global Markets, and Investment Banking & Capital Markets divisions. It currently has negative earnings. The firm offers advisory and financial solutions, such as structured advisory, investment advisory, discretionary asset management, mergers and acquisitions transactions, corporate sales and restructurings, divestitures, takeover defense strategies, equity and fixed income sales, trading, debt and equity securities, spin-offs, debt and equity underwritings, private placements, and derivative products, as well as proprietary and third-party services and products.

Among 6 analysts covering Fibrocell Science (NASDAQ:FCSC), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Fibrocell Science had 11 analyst reports since September 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by TH Capital given on Tuesday, December 22. The stock of Fibrocell Science, Inc. (NASDAQ:FCSC) earned “Buy” rating by H.C. Wainwright on Tuesday, January 16. On Tuesday, December 22 the stock rating was initiated by Roth Capital with “Buy”. On Tuesday, September 26 the stock rating was maintained by H.C. Wainwright with “Buy”. The firm has “Buy” rating given on Wednesday, August 9 by H.C. Wainwright. The firm has “Buy” rating given on Thursday, October 5 by H.C. Wainwright. The rating was maintained by H.C. Wainwright on Friday, June 9 with “Buy”. The rating was downgraded by Wedbush to “Neutral” on Monday, September 28. The company was maintained on Tuesday, January 30 by H.C. Wainwright.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>